Dilemma of further therapeutic step in remitting-relapsing multiple sclerosis in case of ineffectiveness of first-line treatment : fingolimod or natalizumab?
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:67 |
|---|---|
| Enthalten in: |
Ideggyogyaszati szemle - 67(2014), 3-4 vom: 30. März, Seite 141 |
| Sprache: |
Ungarisch |
|---|
| Weiterer Titel: |
Terápiás továbblépés dilemmája relapszáló-remittáló sclerosis multiplexben az elsö vonalbeli kezelés hatástalansága esetén: fingolimod vagy natalizumab? |
|---|
| Beteiligte Personen: |
Gábor, Lovas [VerfasserIn] |
|---|
| Themen: |
Antibodies, Monoclonal, Humanized |
|---|
| Anmerkungen: |
Date Completed 19.08.2015 Date Revised 19.11.2015 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM250377411 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM250377411 | ||
| 003 | DE-627 | ||
| 005 | 20231224155612.0 | ||
| 007 | tu | ||
| 008 | 231224s2014 xx ||||| 00| ||hun c | ||
| 028 | 5 | 2 | |a pubmed24n0834.xml |
| 035 | |a (DE-627)NLM250377411 | ||
| 035 | |a (NLM)26118259 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a hun | ||
| 100 | 1 | |a Gábor, Lovas |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Dilemma of further therapeutic step in remitting-relapsing multiple sclerosis in case of ineffectiveness of first-line treatment |b fingolimod or natalizumab? |
| 246 | 3 | 3 | |a Terápiás továbblépés dilemmája relapszáló-remittáló sclerosis multiplexben az elsö vonalbeli kezelés hatástalansága esetén: fingolimod vagy natalizumab? |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 19.08.2015 | ||
| 500 | |a Date Revised 19.11.2015 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Immunosuppressive Agents |2 NLM | |
| 650 | 7 | |a Natalizumab |2 NLM | |
| 650 | 7 | |a Propylene Glycols |2 NLM | |
| 650 | 7 | |a Fingolimod Hydrochloride |2 NLM | |
| 650 | 7 | |a G926EC510T |2 NLM | |
| 650 | 7 | |a Sphingosine |2 NLM | |
| 650 | 7 | |a NGZ37HRE42 |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Ideggyogyaszati szemle |d 1954 |g 67(2014), 3-4 vom: 30. März, Seite 141 |w (DE-627)NLM119915138 |x 0019-1442 |7 nnns |
| 773 | 1 | 8 | |g volume:67 |g year:2014 |g number:3-4 |g day:30 |g month:03 |g pages:141 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 67 |j 2014 |e 3-4 |b 30 |c 03 |h 141 | ||